Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal triamcinolone prior to macular laser for clinically significant diabetic macular oedema
2004-005043-97Phase 4Unknown
- Sponsor
- St Mary's Hospital NHS Trust
- Start
- Apr 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of triamcinolone acetonide in diabetic macular edema (DME) and diabetic retinopathy (DR) (2 arms), sponsored by St Mary's Hospital NHS Trust. Primary endpoint: Visual acuity improvement. Status: unknown.
02
Drugs
triamcinolone acetonide
03
Conditions
diabetic macular edema (DME)diabetic retinopathy (DR)
Beyond the preview
Go deeper on 2004-005043-97.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005043-97.